| [1] |
Mustafa AM, Angeloni S, Abouelenein D, Acquaticci L, Xiao J, et al. 2022. A new HPLC-MS/MS method for the simultaneous determination of 36 polyphenols in blueberry, strawberry and their commercial products and determination of antioxidant activity. |
| [2] |
Duan Y, Tarafdar A, Chaurasia D, Singh A, Bhargava PC, et al. 2022. Blueberry fruit valorization and valuable constituents: a review. |
| [3] |
Herrera-Balandrano DD, Chai Z, Hutabarat RP, Beta T, Feng J, et al. 2021. Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK activation: in vitro and in vivo studies. |
| [4] |
Yan Y, Zhang F, Chai Z, Liu M, Battino M, et al. 2019. Mixed fermentation of blueberry pomace with L. rhamnosus GG and L. plantarum-1: enhance the active ingredient, antioxidant activity and health-promoting benefits. |
| [5] |
Negi T, Kumar Y, Sirohi R, Singh S, Tarafdar A, et al. 2022. Advances in bioconversion of spent tea leaves to value-added products. |
| [6] |
Kuntz S, Kunz C, Rudloff S. 2017. Inhibition of pancreatic cancer cell migration by plasma anthocyanins isolated from healthy volunteers receiving an anthocyanin-rich berry juice. |
| [7] |
Whyte AR, Rahman S, Bell L, Edirisinghe I, Krikorian R, et al. 2021. Improved metabolic function and cognitive performance in middle-aged adults following a single dose of wild blueberry. |
| [8] |
Zhuge Q, Zhang Y, Liu B, Wu M. 2020. Blueberry polyphenols play a preventive effect on alcoholic fatty liver disease C57BL/6 J mice by promoting autophagy to accelerate lipolysis to eliminate excessive TG accumulation in hepatocytes. |
| [9] |
Wang Y, Cheng M, Zhang B, Nie F, Jiang H. 2013. Dietary supplementation of blueberry juice enhances hepatic expression of metallothionein and attenuates liver fibrosis in rats. |
| [10] |
Feng J, Wang C, Liu T, Li J, Wu L, et al. 2019. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis. |
| [11] |
Ju S, Mu J, Dokland T, Zhuang X, Wang Q, et al. 2013. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. |
| [12] |
Wang Q, Ren Y, Mu J, Egilmez NK, Zhuang X, et al. 2015. Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. |
| [13] |
Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, et al. 2016. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. |
| [14] |
Takakura H, Nakao T, Narita T, Horinaka M, Nakao-Ise Y, et al. 2022. Citrus limon L.-derived nanovesicles show an inhibitory effect on cell growth in p53-inactivated colorectal cancer cells via the macropinocytosis pathway. |
| [15] |
Liu R, Zhang F, He X, Huang K. 2025. Plant derived exosome-like nanoparticles and their therapeutic applications in glucolipid metabolism diseases. |
| [16] |
Thawley V. 2017. Acute liver injury and failure. |
| [17] |
Ramachandran A, Jaeschke H. 2018. Oxidative stress and acute hepatic injury. |
| [18] |
Maiwall R, Kulkarni AV, Arab JP, Piano S. 2024. Acute liver failure. |
| [19] |
Lu K, Shen SY, Luo OY, Lu Y, Shi TS, et al. 2022. Manipulating PP2Acα-ASK-JNK signaling to favor apoptotic over necroptotic hepatocyte fate reduces the extent of necrosis and fibrosis upon acute liver injury. |
| [20] |
Lin F, Chen W, Zhou J, Zhu J, Yao Q, et al. 2022. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. |
| [21] |
De Robertis M, Sarra A, D'Oria V, Mura F, Bordi F, et al. 2020. Blueberry-derived exosome-like nanoparticles counter the response to TNF-α-induced change on gene expression in EA.hy926 cells. |
| [22] |
Rezakhani L, Alizadeh M, Sharifi E, Soleimannejad M, Alizadeh A. 2021. Isolation and characterization of crab haemolymph exosomes and its effects on breast cancer cells (4T1). |
| [23] |
Wang F, Li L, Deng J, Ai J, Mo S, et al. 2025. Lipidomic analysis of plant-derived extracellular vesicles for guidance of potential anti-cancer therapy. |
| [24] |
Tian Y, Liu X, Chen X, Wang B, Dong M, et al. 2024. Integrated untargeted metabolome, full-length sequencing and transcriptome analyses reveal the mechanism of flavonoid biosynthesis in blueberry (Vaccinium spp.) fruit. |
| [25] |
Wang Y, Zhang Q, Kan M, Chang F, He X, et al. 2024. Multi-omics analysis of Au@Pt nanozyme for the modulation of glucose and lipid metabolism. |
| [26] |
Sellers RS, Mortan D, Michael B, Roome N, Johnson JK, et al. 2007. Society of toxicologic pathology position paper: organ weight recommendations for toxicology studies. |
| [27] |
Yi M, Zhang D, Song B, Zhao B, Niu M, et al. 2022. Increased expression of ECT2 predicts the poor prognosis of breast cancer patients. |
| [28] |
Liang FG, Zandkarimi F, Lee J, Axelrod JL, Pekson R, et al. 2024. OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response. |
| [29] |
Liu H, Dong T, Dong C, Yang F, Zhou Q, et al. 2025. Plant-derived exosome-like nanovesicles: a novel therapeutic perspective for skin diseases. |
| [30] |
Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, et al. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. |
| [31] |
Yang M, Guo J, Li J, Wang S, Sun Y, et al. 2025. Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota. |
| [32] |
Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, et al. 2020. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. |
| [33] |
Lian MQ, Chng WH, Liang J, Yeo HQ, Lee CK, et al. 2022. Plant-derived extracellular vesicles: recent advancements and current challenges on their use for biomedical applications. |
| [34] |
Yuan S, Wei C, Liu G, Zhang L, Li J, et al. 2022. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. |
| [35] |
You JY, Kang SJ, Rhee WJ. 2021. Isolation of cabbage exosome-like nanovesicles and investigation of their biological activities in human cells. |
| [36] |
Munagala R, Aqil F, Jeyabalan J, Gupta RC. 2016. Bovine milk-derived exosomes for drug delivery. |
| [37] |
Gong L, Zhou H, Zhang Y, Wang C, Fu K, et al. 2023. Preparation of Phillygenin-Hyaluronic acid composite milk-derived exosomes and its anti-hepatic fibrosis effect. |
| [38] |
Liu B, Nguyen PL, Yu H, Li X, Wang H, et al. 2024. Honey vesicle-like nanoparticles protect aged liver from non-alcoholic steatohepatitis. |
| [39] |
Jiang M, Li F, Liu Y, Gu Z, Zhang L, et al. 2023. Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation. |
| [40] |
Chen J, Zhong K, Jing Y, Liu S, Qin S, et al. 2023. Procyanidin B2: a promising multi-functional food-derived pigment for human diseases. |
| [41] |
Yang BY, Zhang XY, Guan SW, Hua ZC. 2015. Protective effect of procyanidin B2 against CCl4-induced acute liver injury in mice. |
| [42] |
Xing YW, Lei GT, Wu QH, Jiang Y, Huang MX. 2019. Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. |
| [43] |
Su H, Li Y, Hu D, Xie L, Ke H, et al. 2018. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state. |
| [44] |
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, et al. 2012. Ferroptosis: an iron-dependent form of nonapoptotic cell death. |
| [45] |
Cruz-Gregorio A, Aranda-Rivera AK. 2023. Quercetin and ferroptosis. |
| [46] |
Wang Y, Branicky R, Noë A, Hekimi S. 2018. Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. |
| [47] |
Su L, Zhang J, Gomez H, Kellum JA, Peng Z. 2023. Mitochondria ROS and mitophagy in acute kidney injury. |
| [48] |
Lu S, Wang XZ, He C, Wang L, Liang SP, et al. 2021. ATF3 contributes to brucine-triggered glioma cell ferroptosis via promotion of hydrogen peroxide and iron. |
| [49] |
Okazaki S, Umene K, Yamasaki J, Suina K, Otsuki Y, et al. 2019. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma. |
| [50] |
Seiler A, Schneider M, Förster H, Roth S, Wirth EK, et al. 2008. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. |
| [51] |
Chen X, Yu C, Kang R, Kroemer G, Tang D. 2021. Cellular degradation systems in ferroptosis. |
| [52] |
Klaassen CD, Reisman SA. 2010. Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. |
| [53] |
Yang WH, Lin CC, Wu J, Chao PY, Chen K, et al. 2021. The hippo pathway effector YAP promotes ferroptosis via the E3 ligase SKP2. |
| [54] |
Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, et al. 2017. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. |
| [55] |
Lei G, Mao C, Yan Y, Zhuang L, Gan B. 2021. Ferroptosis, radiotherapy, and combination therapeutic strategies. |
| [56] |
Conrad M, Pratt DA. 2019. The chemical basis of ferroptosis. |
| [57] |
Xue P, Zhang J, Wang Z, Wu L, Tang J, et al. 2025. Arachidonic acid induces ferroptosis in hepatocellular carcinoma via the SIRT5-ACSL4/LPCAT3/ALOX15 axis, leading to lipid peroxidation and mitochondrial dysfunction. |
| [58] |
Zhou X, Xu S, Zhang Z, Tang M, Meng Z, et al. 2024. Gouqi-derived nanovesicles (GqDNVs) inhibited dexamethasone-induced muscle atrophy associating with AMPK/SIRT1/PGC1α signaling pathway. |
| [59] |
Yang J, Yun X, Zheng W, Zhang H, Yan Z, et al. 2025. Nanoscale engineered exosomes for dual delivery of Sirtuin3 and insulin to ignite mitochondrial recovery in myocardial ischemia-reperfusion. |
| [60] |
Liu J, Ren Z, Yang L, Zhu L, Li Y, et al. 2022. The NSUN5-FTH1/FTL pathway mediates ferroptosis in bone marrow-derived mesenchymal stem cells. |
| [61] |
Li D, Lu X, Xu G, Liu S, Gong Z, et al. 2023. Dihydroorotate dehydrogenase regulates ferroptosis in neurons after spinal cord injury via the P53-ALOX15 signaling pathway. |
| [62] |
Ren X, Wen Y, Yuan M, Li C, Zhang J, et al. 2024. Cerebroprotein hydrolysate-I ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via the p53/SAT1/ALOX15 signalling pathway. |